Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Angiodynamics (ANGO) over the last 16 years, with Q4 2025 value amounting to $1.6 million.

  • Angiodynamics' Change in Receivables fell 5800.75% to $1.6 million in Q4 2025 from the same period last year, while for Nov 2025 it was $1.5 million, marking a year-over-year increase of 12003.58%. This contributed to the annual value of -$23000.0 for FY2025, which is 9970.86% up from last year.
  • According to the latest figures from Q4 2025, Angiodynamics' Change in Receivables is $1.6 million, which was down 5800.75% from -$139000.0 recorded in Q3 2025.
  • In the past 5 years, Angiodynamics' Change in Receivables ranged from a high of $10.7 million in Q2 2022 and a low of -$5.5 million during Q2 2024
  • Its 5-year average for Change in Receivables is $692150.0, with a median of $255000.0 in 2021.
  • In the last 5 years, Angiodynamics' Change in Receivables soared by 385833.33% in 2022 and then crashed by 36963.07% in 2024.
  • Angiodynamics' Change in Receivables (Quarter) stood at $2.9 million in 2021, then crashed by 114.07% to -$406000.0 in 2022, then soared by 710.84% to $2.5 million in 2023, then soared by 50.56% to $3.7 million in 2024, then tumbled by 58.01% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q4 2025, -$139000.0 for Q3 2025, and -$447000.0 during Q2 2025.